Dayvigo: payments to doctors
Payments that named Dayvigo as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.1M
- Providers
- 29,242
- Transactions
- 87,080
- Average per transaction
- $47
The per-transaction average — $47 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 29,242 providers the average total is $139, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Eisai Inc. | $4,016,779 | 98.9% |
| Eisai Co., Ltd. | $43,873 | 1.1% |